½ÃÀ庸°í¼­
»óǰÄÚµå
1493361

¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° ºÎ¹® ¿¹Ãø(2024-2030³â)

U.S. Dermatology Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic Devices, Treatment Devices), By Application, By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 70 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå ±Ô¸ð´Â m2030³â±îÁö 127¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁöÀÇ CAGRÀº 12.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇǺΰú ±â±âÀÇ ±â¼úÀû Áøº¸¿Í ÇǺΠÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù. ¹Ì±¹ÀÇ ÇǺΰúÇÐȸ¿¡ µû¸£¸é, ¿©µå¸§°ú À¯»çÇÑ ÇǺÎÁúȯÀº ¹Ì±¹¿¡¼­ ¿¬°£ 5,000¸¸ ¸í ÀÌ»ó¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù.

°íµµ·Î °³¹ßµÈ ±¤Ä¡·á±â±â, ¹Ì¼¼¹ÚÇǼú±â±â, ·¹ÀÌÀú±â±â´Â ÇǺΰú Àü¹®°¡µéÀÌ Ä§½À¼ºÀÌ ³·°í º¸´Ù È¿°úÀûÀÎ Ä¡·á¸¦ ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. Á¦Á¶¾÷ü °¢»ç´Â ÇǺΠÁúȯ Ä¡·á¸¦ À§ÇÑ Çõ½ÅÀûÀÎ ÀÇ·á±â±âÀÇ °³¹ß¡¤»ó½Ã¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì¿ë ÀÇ·á±â±âÀÇ °³¹ß ¹× Á¦Á¶ ȸ»çÀÎ Cytrellis, Inc.´Â 2022³â 7¿ù¿¡ ±â¾÷ÀÇ Á¦Ç°ÀÎ EllacorÀÇ FDA ½ÂÀÎÀ» ¹Þ¾Ò½À´Ï´Ù. Ellacor´Â Á¶Á÷ÀÇ ¸¶ÀÌÅ©·Î ÄÚ¾îÈ­¸¦ ÀÌ¿ëÇÏ¿© ÅëÁõÀÌ Àû°í ÈäÅͰ¡ ³²Áö ¾Ê´Â µîÀÇ ÀÌÁ¡À» °¡Áø ÇǺΠġ·á¸¦ Á¦°øÇÕ´Ï´Ù.

ÇǺΠÁúȯÀÇ Á¶±â Áø´Ü°ú Ä¡·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡´Â ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÕ´Ï´Ù. ¶ÇÇÑ °æÁ¦ºÐ¼®±¹¿¡ µû¸£¸é ¹Ì±¹ÀÇ °¡Ã³ºÐ¼ÒµæÀº 2024³â 1¿ù 676¾ï ´Þ·¯ Áõ°¡ÇßÀ¸¸ç °³ÀÎ ¼Òºñ ÁöÃâÀº 439¾ï ´Þ·¯ Áõ°¡Çß½À´Ï´Ù. °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇǺΠŸÀÌÆ®´×°ú ÇǺΠ¸®¼­ÆäÀÌ½Ì µî ÇʼöÀûÀÌÁö ¾ÊÀº ÇǺΠġ·á¿¡ ´ëÇÑ ÁöÃâÀÌ Áõ°¡ÇÏ°í ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¹Ì±¹¼ºÇü¿Ü°úÇÐȸ´Â ¿©·ÐÁ¶»ç¿¡ ±Ù°ÅÇÏ¿© À¯¹æÇб³ ÀÌÈÄ 75% ÀÌ»óÀÇ ¼ºÇü¿Ü°ú º´¿øÀÌ ½ÇÀûÀ» ´Ã¸®°í ¾à 30%ÀÇ °³¾÷Àǰ¡ 100%ÀÇ ½ÇÀû Áõ°¡¸¦ º¸°íÇϰí ÀÖÀ½À» ¹àÇû½À´Ï´Ù. Forbes Health-IpsosÀÇ Á¶»ç¿¡ µû¸£¸é, À¯ÇàÀº °³ÀÎµé »çÀÌ¿¡¼­ ½Åü À̹ÌÁö¿¡ ´ëÇÑ ºÎÁ¤ÀûÀÎ °ü³äÀ» Áõ°¡½ÃÄÑ ÇǺΰú ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù.

¹Ì±¹ÀÇ ÇǺΰú±â±â ½ÃÀå º¸°í¼­?ÇÏÀ̶óÀÌÆ®

  • Ä¡·á ±â±â ºÐ¾ß´Â Ä¡·á ±â±âÀÇ ±¤¹üÀ§ÇÑ Àû¿ë¼ºÀ¸·Î 2023³â¿¡ 79.5%ÀÇ ÃÖ´ë ÆÇ¸Å Á¡À¯À²·Î ½ÃÀåÀ» ¼±µµÇß½À´Ï´Ù. ¶ÇÇÑ, ¹®½Å Á¦°Å¿Í °°Àº Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇǺΰú Ä¡·á ±â±â ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ÇöÀúÇÑ ¿äÀÎÀÔ´Ï´Ù.
  • ¿ëµµº°·Î´Â Ä¡·á ºÐ¾ß°¡ 2023³â¿¡ °¡Àå Å« ¼öÀÍ Á¡À¯À²À» Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À̰ÍÀº ÇǺΠġ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÇǺΠ°ü¸®¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö±â ¶§¹®ÀÔ´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î ±¤¹üÀ§ÇÑ ÇǺΠġ·á ¿É¼ÇÀ» »ç¿ëÇÒ ¼ö Àֱ⠶§¹®¿¡ º´¿ø ºÎ¹®ÀÌ 2023³â ´ëºÎºÐÀÇ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • Ŭ¸®´Ð ºÐ¾ß´Â ´ë±â ½Ã°£ÀÌ Âª°í Àü±¹¿¡ ¸¹Àº Ŭ¸®´ÐÀÌ Á¸ÀçÇÑ´Ù´Â ÀåÁ¡À¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀåÀÇ º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå : Á¦Ç°ÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

  • Á¦Ç° ½ÃÀå Á¡À¯À², 2023³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå :Á¦Ç°º° Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®(2018-2030³â)

Á¦5Àå ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå :Áö¿ª ÃßÁ¤ ¹× µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À², 2023³â¡¤2030³â
  • ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå :Áö¿ªº° Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®(2018-2030³â)

Á¦6Àå ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå : ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ¿ëµµ ½ÃÀå Á¡À¯À², 2023³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå : ¿ëµµº° Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®(2018-2030³â)

Á¦7Àå ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµÀÇ ÃßÁ¤ ¹× µ¿Ç⠺м®

  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2023³â¡¤2030³â
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ÇǺΰú ±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº° Àü¸Á
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®(2018-2030³â)

Á¦8Àå °æÀï ±¸µµ

  • ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м® : ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷º°
  • ±â¾÷/ °æÀïÀÇ ºÐ·ù
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Cutera, Inc.
    • Genesis Biosystems, Inc.
    • Cytrellis, Inc.
    • Candela Medical Corporation
    • Bausch Health Companies Inc.
    • DermLite.
    • Cynosure Inc.
    • Avita Medical, Inc,
    • Skin Science Solutions, Inc.
    • Canfield Scientific, Inc.
JHS 24.06.20

U.S. Dermatology Devices Market Growth & Trends:

The U.S. dermatology devices market size is anticipated to reach USD 12.73 billion by 2030 and is projected to grow at a CAGR of 12.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Technological advancements in dermatology devices and the rising prevalence of skin disorders are some of the factors driving the market growth. According to the American Academy of Dermatology Association, acne, and similar skin conditions affect over 50 million people in the U.S. annually.

Highly developed light therapy devices, microdermabrasion devices, and laser devices help dermatology professionals deliver less invasive and more effective treatments. Manufacturers are focusing on developing and launching innovative medical devices for treating skin conditions. For instance, Cytrellis, Inc., a developer and manufacturer of aesthetic medical devices, received its FDA approval in July 2022 for its product Ellacor, which uses tissue micro-coring to deliver skin treatments that are less painful and non-scarring, among other benefits.

Growing awareness regarding early diagnosis and treatment of skin disorders has contributed to the market growth. In addition, according to the Bureau of Economic Analysis, disposable personal income in the U.S. increased by USD 67.6 billion, and personal consumption expenditure increased by USD 43.9 billion in January 2024. As disposable income rises, expenditure on non-essential skin treatments, such as skin tightening and skin resurfacing, among others, is anticipated to increase and boost the market growth.

The American Society of Plastic Surgeons uncovered, based on a poll, that more than 75% of plastic surgery practices gained more business after the pandemic, with approximately 30% of practitioners reporting a 100% increase in business. According to a Forbes Health-Ipsos survey, the pandemic increased negative notions of body image among individuals, which has been increasing the demand for dermatology services.

U.S. Dermatology Devices Market Report Highlights:

  • The treatment devices segment led the market with the largest revenue share of 79.5% in 2023, owing to the broad applicability of treatment devices. Moreover, the increasing demand for procedures such as tattoo removal is a notable factor fueling the demand for dermatology treatment devices
  • Based on application, the treatment segment accounted the market with the largest revenue share in 2023 and is projected to grow at the fastest CAGR over the forecast period, owing to rising demand for skin treatments and growing awareness regarding skin care
  • Based on end-use, the hospitals segment held a majority share in 2023, due to the availability of a wide range of skin treatment options
  • The clinics segment is projected to grow at the fastest CAGR during the forecast period, owing to the benefit of shorter waiting periods and a large number of clinics present across the nation

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Dermatology Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Dermatology Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Dermatology Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Dermatology Devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Diagnostic devices
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.1.1. Dermatoscope
      • 4.4.1.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1.2. Microscopes
      • 4.4.1.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1.3. Other Imaging Devices
      • 4.4.1.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1.4. Biopsy Devices
      • 4.4.1.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Treatment devices
      • 4.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.1. Light Therapy Devices
      • 4.4.2.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.2. Lasers
      • 4.4.2.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.3. Electrosurgical Equipment
      • 4.4.2.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.4. Liposuction Devices
      • 4.4.2.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.5. Microdermabrasion Devices
      • 4.4.2.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.2.1.6. Cryotherapy Devices
      • 4.4.2.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. U.S. Dermatology Devices Market: Region Estimates & Trend Analysis

  • 5.1. Regional Market Share, 2023 & 2030
  • 5.2. U.S. Dermatology Devices Market by Region Outlook
  • 5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.3.1. West
      • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Midwest
      • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.3. Northeast
      • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.4. Southwest
      • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.5. Southeast
      • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Dermatology Devices Market: Application Estimates & Trend Analysis

  • 6.1. Application Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Dermatology Devices Market by Application Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Diagnostics Application
      • 6.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.1.1. Skin Cancer Diagnosis
      • 6.4.1.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.1.2. Other
      • 6.4.1.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Treatment application
      • 6.4.2.1. Treatment application market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.1. Hair Removal
      • 6.4.2.1.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.2. Skin Rejuvenation
      • 6.4.2.1.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.3. Acne, Psoriasis, and Tattoo Removal
      • 6.4.2.1.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.4. Wrinkle Removal and Skin Resurfacing
      • 6.4.2.1.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.5. Body Contouring and Fat Removal
      • 6.4.2.1.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.6. Vascular and Pigmented Lesion Removal
      • 6.4.2.1.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.2.1.7. Others
      • 6.4.2.1.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. U.S. Dermatology Devices Market: End-use Estimates & Trend Analysis

  • 7.1. End-use Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. U.S. Dermatology Devices Market by End-use Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 7.4.1. Hospitals
      • 7.4.1.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Clinics
      • 7.4.2.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. Others
      • 7.4.3.1. Market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Company Profiles
    • 8.3.1. Cutera, Inc.
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Genesis Biosystems, Inc.
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Cytrellis, Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Candela Medical Corporation
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Bausch Health Companies Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. DermLite.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Cynosure Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Avita Medical, Inc,
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Skin Science Solutions, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Canfield Scientific, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦